It has been proposed that the higher number of bone marrow adipocytes in CKD patients, as compared to healthy individuals, may contribute to higher circulating levels of adiponectin [64]; moreover, they were negatively correlated with hematopoiesis [65], suggesting a close relationship between adiponectin and the development of anemia in CKD patients. Here, ADIPOQ is linked to chronic kidney disease.